In a bid to address the looming crisis facing Korea's stroke treatment system, Korean Stroke Society (KSS) held a press conference at the Westin Josun Seoul aimed to dissect the current state of stroke care in the country and propose strategies to strengthen the healthcare infrastructure, especially
Y-Biologics said Wednesday that it has signed a licensing-out deal with VaxCell Bio, a company specializing in anticancer immune cell therapies, for its anti-PD-L1 antibody “YBL-007” sequence.Under the agreement, VaxCell Bio has the exclusive right to use the YBL-007 sequence in the research, develo
Huons' sales exceeded 500 billion won ($375 million) last year, thanks to increased pharmaceutical exports and efficient management of sales and management expenses.In a public filing on Wednesday, the company disclosed its preliminary consolidated operating results for 2023.According to the disclos
After posting strong growth last year, Boryung aims to continue its momentum this year and join the “Trillion Won Club.” The company's confidence is fueled by increased sales across all business areas and success in the anticancer area.Boryung CEO Chang Doo-hyun (Daniel Chang) recently met with repo
A study by researchers at Seoul National University Bundang Hospital (SNUBH) showed that the use of digital healthcare among older adults is poor, with half of the participants unable to install related applications despite smartphone use.Digital healthcare technology, including a wide range of heal
In a notable legal development, Hugel has secured a favorable outcome in its legal battles against the Ministry of Food and Drug Safety (MFDS) regarding the indirect export of Botulax, its botulinum toxin (BTX) products, which led to the revocation of its sales license. The Seoul Administrative Cour
Many Korean pharma and biotech companies posted record-breaking results last year. Still, those focusing on the vaccine business, including GC Biopharma and SK bioscience, performed relatively poorly as the Covid-19 pandemic eased to an endemic.According to GC Biopharma’s preliminary consolidated op
"Taking Sugatree is like catching two birds with one stone, as it offers both ease of administration and cost-effectiveness."Dong-A ST's employees at the Diabetes Division of the Marketing 2 team of the ETC Business Headquarters said so in unison.Sugatree XR Tablet is a diabetes treatment combinatio
Samsung Biologics said it has obtained the "Leadership A-"grade, the second highest of the eight grades, from Carbon Disclosure Project (CDP), a global sustainability assessment organization, for its climate change response efforts in 2023.The company stressed that it is the first in the domestic bi
Hanmi Pharm CEO Lim Jong-yoon, the eldest son of the late Lim Sung-ki, who founded the Hanmi Pharmaceutical Group, and his younger, Hanmi Science CEO Lim Jong-hoon, have announced their intention to change the management of Hanmi Science.They plan to form a new board of directors through the shareho
“Cardiothoracic surgery is 19.57 to 1, and general surgery is 3.4 to 1.”Of course, this is not the case in Korea. These were the competition rates for medical specialties in the U.K. in 2022. Unlike Korea, “vital departments” like cardiothoracic surgery and general surgery are popular among doctors
Handok said it decided to establish a local joint venture with Swedish Orphan Biovitrum (Sobi), a global biopharmaceutical company specializing in rare diseases, in the first half of this year.Sobi is a global biopharmaceutical company specializing in rare diseases, providing innovative treatments i
JW Pharmaceuticals announced on Tuesday that interim results from a study showcasing the efficacy and safety of Hemlibra (emicizumab) in hemophilia A patients younger than one year old were recently published in the international journal Blood.Dr. Steven Pipe, professor of pediatrics at the Universi
It's a new year, the time when many commit to living a healthier life. To succeed, remember this: focus on short-term goals rather than long-term ones. Humans often prioritize immediate benefits over future ones, a phenomenon known as preference reversal over time in behavioral economics.Dermatologi
Hugel said it showcased new clinical findings for its botulinum toxin (BTX) product at the 25th International Master Course on Aging Science (IMCAS) World Congress, held in Paris, France, from Feb. 1 to 3.The event, which is recognized as the world's largest conference on aesthetic plastic surgery,
The Ministry of Health and Welfare has dismissed as untrue claims that the increase in medical school enrollment quotas is for election purposes and that the government and medical community will adjust the size of the increase after the election.The ministry added that the increased medical school
Tevimbra (tislelizumab), an anti-PD-1 immunotherapy developed by BeiGene, has begun the process of seeking reimbursement in Korea.BeiGene's stance of supplying innovative new drugs at reasonable prices is drawing attention to whether it could alleviate the growing financial burden caused by high-pri
Yuhan Corp. will hold its annual shareholders' meeting next month and decide whether to reappoint Cho Wook-je as its president and CEO. Industry officials watch with interest whether Cho will serve another term.The company issued a public notice last Tuesday, announcing that it would hold its annual
Celltrion said it has completed its application for marketing authorization to the European Medicines Agency (EMA) for CT-P47, a biosimilar referencing Actemra.Roche's Actemra (ingredient: tocilizumab), known as RoActemra in Europe, is approved for a wide range of conditions, including rheumatoid ar
A new treatment has landed in Korea for moderate to severe active ulcerative colitis that has not responded adequately to standard treatments or biologics or has become unresponsive.Lilly Korea said Thursday that the interleukin-23 (IL-23) inhibitor Omvoh (mirikizumab) has received approval from the